The European market for hospital-acquired disease testing, valued at USD 4.13 billion in 2024, is expected to expand at a Compound Annual Growth Rate (CAGR) of 1.89% from 2025 to 2033, reaching an estimated worth of USD 4.89 billion by 2033. Also termed as nosocomial infections, hospital-acquired diseases are infections that patients contract during their…